Recall Register

Food, drugs, devices › Randox Laboratories Ltd.

Device recall: Calibration Serum Level 3. CAL 3, REF CAL2351. Human Assayed Multi-Sera Level 2 (HN1530) Human Assayed Multi-Sera Level

FDA enforcement event 93602 · Class II · initiated 13 Nov 2023 · status Ongoing

DeviceVoluntary: Firm initiated1 product recordCrumlin (North), N/A

FDA enforcement event 93602 is a device recall by Randox Laboratories Ltd. of Crumlin (North), N/A, initiated 13 Nov 2023 and classified Class II, with 1 product record.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 88% of the 917 device enforcement events initiated in 2023 carry the same class.

Status: Ongoing. Initiation: voluntary: firm initiated. Randox Laboratories Ltd. has 52 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Randox Laboratories Ltd., Crumlin (North), N/A, Ireland.

Reason for recall

"There have been transcription errors on the Instructions For Use (IFU) of the Calibration Serum Level 3 (CAL2351 lot 1260UE, 1262UE and 1315UE) for target values of Bilirubin and Triglycerides, on the IFU of Human Assayed Multi-Sera Level 2 (HN1530) for TBIC taget value and on IFU of Human Assayed Multi-Sera Level 3 (HE 1532) for Lipase target value."

Distribution

"US Nationwide distribution."

Product records

Recall numberProductQuantityClassStatusReport date
Z-0751-2024Calibration Serum Level 3. CAL 3, REF CAL2351. Human Assayed Multi-Sera Level 2 (HN1530) Human Assayed Multi-Sera Level 3 (HE 1532)N/AClass IIOngoing24 Jan 2024

Context

88%of 2023 device events are Class II917 events that year
1product record in this eventfirm median: 1
52events on this register for the firm

Other enforcement events for Randox Laboratories Ltd.

InitiatedProduct (first record)TypeClassRecords
7 Jun 2024RX Series CYSC- Cystatin C Reagent -Intended for in vitro diagnostic (IVD) use as Randox Cystatin C assay on automated aDeviceClass II1
5 Apr 2024Evidence MultiSTAT with software v 3.7-Analyzer intended for the qualitative determination of parent drug molecule and mDeviceClass III1
5 Mar 2024Clinical Chemistry Calibration Serum (Catalog number Cal2351) that is 20x5ml lyophilized human based serum covering 38 cDeviceClass II1
1 Mar 2024Liquid Protein Calibrators. C3 and Haptoglobin liquid protein calibrators used with Randox IgA, IgG, and IgM assays thatDeviceClass II1
14 Feb 2024Cystatin C Calibrator - In vitro diagnostic (IVD) use in the calibration of the Randox Cystatin C assay on automated anaDeviceClass II1
31 Jan 2024Microalbumin Calibrator Series (mALB CAL)-IVD used to calibrate the Microalbumin Assay Catalog Number: MA1567DeviceClass II2
29 Nov 2023RX Series Copper (Cu) Assay Ref. Number CU2340DeviceClass II1
20 Nov 2023Calibration Serum Level 3 CAL2351DeviceClass II1
20 Nov 2023Calibration Serum Level 3 - IVD For use as a Calibrator in clinical chemistry assays Catalog Number: CAL2351DeviceClass II1
6 Nov 2023SEROLOGY ToRCH lgM 2022 POSITIVE CONTROLI Intended for use with in vitro assays for determination of IgM antibodies to CDeviceClass III1

All 52 events for Randox Laboratories Ltd.

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "There have been transcription errors on the Instructions For Use (IFU) of the Calibration Serum Level 3 (CAL2351 lot 1260UE, 1262UE and 1315UE) for target values of Bilirubin and Triglycerides, on the IFU of Human Assayed Multi-Sera Level 2 (HN1530) for TBIC taget value and on IFU of Human Assayed Multi-Sera Level 3 (HE 1532) for Lipase target value."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "US Nationwide distribution."

Is the recall still ongoing?

FDA lists the status as Ongoing. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.